123 related articles for article (PubMed ID: 11353809)
21. A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling.
Peräkylä M; Molnár F; Carlberg C
Chem Biol; 2004 Aug; 11(8):1147-56. PubMed ID: 15324816
[TBL] [Abstract][Full Text] [Related]
22. Molecular evaluation of vitamin D3 receptor agonists designed for topical treatment of skin diseases.
Bury Y; Ruf D; Hansen CM; Kissmeyer AM; Binderup L; Carlberg C
J Invest Dermatol; 2001 May; 116(5):785-92. PubMed ID: 11348471
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanism of the vitamin D antagonistic actions of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone depends on the primary structure of the carboxyl-terminal region of the vitamin d receptor.
Ochiai E; Miura D; Eguchi H; Ohara S; Takenouchi K; Azuma Y; Kamimura T; Norman AW; Ishizuka S
Mol Endocrinol; 2005 May; 19(5):1147-57. PubMed ID: 15650022
[TBL] [Abstract][Full Text] [Related]
24. Central role of VDR conformations for understanding selective actions of vitamin D(3) analogues.
Carlberg C; Quack M; Herdick M; Bury Y; Polly P; Toell A
Steroids; 2001; 66(3-5):213-21. PubMed ID: 11179728
[TBL] [Abstract][Full Text] [Related]
25. 1alpha,25-dihydroxyvitamin D(3)-26,23-lactone analogs antagonize differentiation of human leukemia cells (HL-60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells).
Miura D; Manabe K; Gao Q; Norman AW; Ishizuka S
FEBS Lett; 1999 Oct; 460(2):297-302. PubMed ID: 10544253
[TBL] [Abstract][Full Text] [Related]
26. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
27. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor.
Liu YY; Nguyen C; Peleg S
Mol Endocrinol; 2000 Nov; 14(11):1776-87. PubMed ID: 11075811
[TBL] [Abstract][Full Text] [Related]
28. Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands.
Carlberg C
Recent Results Cancer Res; 2003; 164():29-42. PubMed ID: 12899512
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators.
Inaba Y; Yamamoto K; Yoshimoto N; Matsunawa M; Uno S; Yamada S; Makishima M
Mol Pharmacol; 2007 May; 71(5):1298-311. PubMed ID: 17325131
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3.
Cheskis B; Lemon BD; Uskokovic M; Lomedico PT; Freedman LP
Mol Endocrinol; 1995 Dec; 9(12):1814-24. PubMed ID: 8614417
[TBL] [Abstract][Full Text] [Related]
31. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL
Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469
[TBL] [Abstract][Full Text] [Related]
32. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of 20-epi vitamin D analogs on the vitamin D receptor homodimer.
Koszewski NJ; Reinhardt TA; Horst RL
J Bone Miner Res; 1999 Apr; 14(4):509-17. PubMed ID: 10234571
[TBL] [Abstract][Full Text] [Related]
34. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
[TBL] [Abstract][Full Text] [Related]
35. Characterization of vitamin D receptor ligands with cell-specific and dissociated activity.
Castillo AI; Sánchez-Martínez R; Jiménez-Lara AM; Steinmeyer A; Zügel U; Aranda A
Mol Endocrinol; 2006 Dec; 20(12):3093-104. PubMed ID: 16901972
[TBL] [Abstract][Full Text] [Related]
36. Antagonist- and inverse agonist-driven interactions of the vitamin D receptor and the constitutive androstane receptor with corepressor protein.
Lempiäinen H; Molnár F; Macias Gonzalez M; Peräkylä M; Carlberg C
Mol Endocrinol; 2005 Sep; 19(9):2258-72. PubMed ID: 15905360
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
[TBL] [Abstract][Full Text] [Related]
38. (23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease.
Ishizuka S; Kurihara N; Reddy SV; Cornish J; Cundy T; Roodman GD
Endocrinology; 2005 Apr; 146(4):2023-30. PubMed ID: 15618361
[TBL] [Abstract][Full Text] [Related]
39. 9-cis retinoic acid accelerates calcitriol-induced osteocalcin production and promotes degradation of both vitamin D receptor and retinoid X receptor in human osteoblastic cells.
Jääskeläinen T; Ryhänen S; Mäenpää PH
J Cell Biochem; 2003 Aug; 89(6):1164-76. PubMed ID: 12898515
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators.
Issa LL; Leong GM; Sutherland RL; Eisman JA
J Bone Miner Res; 2002 May; 17(5):879-90. PubMed ID: 12009019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
